Derivation and Validation of a Clostridium difficile Infection Recurrence Prediction Rule in a National Cohort of Veterans
- 2 February 2018
- journal article
- research article
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 38 (3) , 349-356
Abstract
Study Objective: Prior studies have identified risk factors for recurrent Clostridium difficile infection (CDI), but few studies have integrated these factors into a clinical prediction rule that can aid clinical decision‐making. The objectives of this study were to derive and validate a CDI recurrence prediction rule to identify patients at risk for first recurrence in a national cohort of veterans.Design: Retrospective cohort study.Data Source: Veterans Affairs Informatics and Computing Infrastructure.Patients: A total of 22,615 adult Veterans Health Administration beneficiaries with first‐episode CDI between October 1, 2002, and September 30, 2014; of these patients, 7538 were assigned to the derivation cohort and 15,077 to the validation cohort.Measurements and Main Results: A 60‐day CDI recurrence prediction rule was created in a derivation cohort using backward logistic regression. Those variables significant at p2 = 0.94). Patients were split into low‐risk (0–2 points), medium‐risk (3–5 points), and high‐risk (6–8 points) classes and had the following recurrence rates: 8.9%, 20.2%, and 35.0%, respectively. Findings were similar in the validation cohort.Conclusion: Several CDI and patient‐specific factors were independently associated with 60‐day CDI recurrence risk. When integrated into a clinical prediction rule, higher risk scores and risk classes were strongly correlated with CDI recurrence. This clinical prediction rule can be used by providers to identify patients at high risk for CDI recurrence and help guide preventive strategy decisions, while accounting for clinical judgment.Keywords
Funding Information
- American College of Clinical Pharmacy Research Institute
- National Institutes of Health (1P30AG044271-01A1)
- National Center for Advancing Translational Sciences (UL1 TR001120)
This publication has 29 references indexed in Scilit:
- Fidaxomicin Versus Vancomycin for Clostridium difficile Infection: Meta-analysis of Pivotal Randomized Controlled TrialsClinical Infectious Diseases, 2012
- Predictors of First Recurrence of Clostridium difficile Infection: Implications for Initial ManagementClinical Infectious Diseases, 2012
- Clostridium difficile infection: new developments in epidemiology and pathogenesisNature Reviews Microbiology, 2009
- Recurrent Clostridium difficile infection: A review of risk factors, treatments, and outcomesJournal of Infection, 2009
- Prospective Derivation and Validation of a Clinical Prediction Rule for Recurrent Clostridium difficile InfectionGastroenterology, 2009
- A Comparison of Vancomycin and Metronidazole for the Treatment of Clostridium difficile-Associated Diarrhea, Stratified by Disease SeverityClinical Infectious Diseases, 2007
- Recurrent Clostridium difficile Diarrhea: Characteristics of and Risk Factors for Patients Enrolled in a Prospective, Randomized, Double-Blinded TrialClinical Infectious Diseases, 1997
- Adapting a clinical comorbidity index for use with ICD-9-CM administrative databasesJournal of Clinical Epidemiology, 1992
- Recurrences of Clostridium difficile Diarrhea Not Caused by the Original Infecting OrganismThe Journal of Infectious Diseases, 1989
- A role for colonic stasis in the pathogenesis of disease related to Clostridium difficileDiseases of the Colon & Rectum, 1986